| Big buy in $EOLS OTM $10 May calls |
| @zonlyz1 |
04/28/2023 5:12:15 PM |
| $EOLS 4Q22 CC transcript: |
| @ezeee |
03/09/2023 9:46:54 PM |
| Yeah.that was the only surprise. They have been |
| @RRaj |
03/09/2023 12:54:57 AM |
| The only surprise is the refreshed $250M shelf |
| @JBJ |
03/09/2023 12:14:12 AM |
| No surprises here. |
| @SirBranimal |
03/08/2023 10:32:20 PM |
| $EOLS reports 4Q22 results: |
| @burill |
03/08/2023 9:16:29 PM |
| Cant wait for Aeon to be done. If |
| @modiddley387 |
02/22/2023 11:19:26 PM |
| Aeon sold 44% of its remaining $EOLS shares |
| @raysodyssey |
02/22/2023 9:12:46 PM |
| I really think you are reaching on this |
| @Sirius |
02/19/2023 1:13:24 AM |
| I dont see that as clearly. But your |
| @Jackie2021 |
02/17/2023 3:39:59 AM |
| What the CEO clearly means by the "not |
| @Chuckyboss |
02/17/2023 1:10:00 AM |
| Comments pertain to what? That they arent including |
| @rocky |
02/17/2023 1:01:28 AM |
| Maybe. Aeon Biopharma ($EOLS' former parent company) does |
| @rgorbal |
02/16/2023 11:43:24 PM |
| There isnt going to be a real accurate |
| @ldickey |
02/16/2023 11:41:54 PM |
| Like it or not, Evolus is going to |
| @2wheelfamily |
02/16/2023 10:32:10 PM |
| LOL? You do understand that they use the |
| @harryparker1uk |
02/16/2023 10:29:30 PM |
| $EOLS 2028 forecast of $500M in sales includes |
| @iggyw1 |
02/14/2023 6:47:50 PM |
| Court_ruling_in_Korea_against Daewoong may_end $EOLS sales_of Jeuveau(a/k/a BTX): |
| @bd49th |
02/10/2023 9:40:56 AM |
| $EOLS' double-dose dataset cannot be trusted... |
| @kjpinvest |
01/30/2023 11:50:48 PM |
| $EOLS CC slides for double-dose Jeuveausee_comments_below: |
| @ARTBOZ |
01/30/2023 11:48:53 PM |
| $EOLS reports double-dose trial_resultssee #msg-171059874 for_commentary: |
| @millssteven02 |
01/28/2023 5:27:24 PM |
| whytestocks: $EOLS News Article - Evolus to Present Phase 2 Interim Data from Jeuveau "Extra-Strength" Dose for |
| @ |
01/23/2023 1:45:52 PM |
| whytestocks: $EOLS News Article - Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Net Re |
| @ |
01/18/2023 3:00:54 PM |
| $EOLS pre-announces 4Q22 Jeuveau sales=$43.6M, +26%YoY: |
| @superdodgeball |
01/18/2023 2:04:11 PM |
| AEON Biopharma goes public via SPAC merger with PMGM: |
| @DAIsf |
12/13/2022 4:03:36 PM |
| whytestocks: $EOLS News Article - Evolus Extends Term of Credit Facility with Pharmakon Advisors |
| @ |
12/08/2022 4:55:47 PM |
| $EOLS 3Q22 results9/30/22 cash=$65.6M: |
| @TerresaWeiler |
11/08/2022 9:22:50 PM |
| $EOLS launches Nuceiva* in UK: |
| @bigburt |
10/04/2022 3:27:20 PM |
| I replied to your post in #msg-170092989.Thanks Dew. |
| @epitcher |
10/02/2022 1:46:34 AM |
| I replied to your post in #msg-170092989. |
| @watjohn |
10/02/2022 1:36:19 AM |
| FWIW, a hedge fund (Caligan Partners) shareholder thoughts |
| @Selim |
10/02/2022 12:14:23 AM |
| $EOLS -8% on reiterated financial guidance: |
| @bunnylender |
09/21/2022 6:37:33 PM |
| $EOLS director bought $90K of stock on the |
| @ScottyStocks |
09/07/2022 8:28:43 PM |
| $EOLS reported $0 of revenue from its Canadian |
| @dirtytrumbone |
08/02/2022 7:50:17 PM |
| Not raising 2022 sales guidanceand what that implies |
| @tiffany0406 |
08/02/2022 7:49:02 PM |
| $EOLS reiterated 2022 sales guidance at the high |
| @renaldoneipp |
08/02/2022 7:47:48 PM |
| $EOLS 2Q22 product_sales=$37.2M6/30/22_cash=$84.5M(down from $106.7M @3/31/22): |
| @Cameron |
08/02/2022 7:44:54 PM |
| $EOLS 1Q22 product_sales=$33.2M3/31/22_cash=$106.7M(down from $146.3M @12/31/21 |
| @Joanwong |
05/10/2022 10:02:32 PM |
| AddendumThe $143-150M guidance for 2022 sales equates to |
| @wenmane |
03/04/2022 1:27:33 AM |
| $EOLS 4Q21 financialsrevenue=$34.7M12/31/21_cash=$146.3M: |
| @COOPER123 |
03/03/2022 9:16:38 PM |
| $EOLS(unaudited)4Q21 sales=$34.7M12/31/21_cash=$146M: |
| @RoadsideTrader |
01/26/2022 6:06:24 PM |
| $EOLSNew $125M credit line: |
| @Ltrades |
12/14/2021 2:52:06 PM |
| $EOLS starting "double-dose" phase-2 trial in glabellar lines |
| @mbweil |
11/02/2021 1:15:41 PM |
| $EOLS 3Q21 sales=$26.7M6/30/21_cash=$108M: |
| @roberto33463 |
11/02/2021 1:13:20 PM |
| $EOLS 2Q21 sales=$26.1M6/30/21_cash=$132M: |
| @bzanon24 |
08/04/2021 8:21:39 PM |
| $EOLS 1Q21 sales=$12.2M3/31/21_pro_forma*_cash=$140M: |
| @Schin10301 |
05/12/2021 8:19:58 PM |
| $EOLS sells 10.35M* shares @$9.50a 19% discount to |
| @jjasura |
04/22/2021 1:50:01 PM |
| $EOLS raising capital again: |
| @raynix |
04/21/2021 8:08:32 PM |
| $EOLS $75M ATM via Leerink: |
| @farml1234 |
03/26/2021 1:04:12 PM |
| whytestocks: $EOLS News Article - Evolus Reports Fourth Quarter and Full Year 2020 Results and Provides Business |
| @ |
03/24/2021 8:25:49 PM |
| $EOLS 4Q20 results: |
| @investingfun |
03/24/2021 8:17:36 PM |
| whytestocks: $EOLS News Article - Evolus Strengthens Balance Sheet Through a $25.5 Million Cash Infusion and Elim |
| @ |
03/23/2021 3:05:49 PM |
| $EOLS issues 3.1M shares to supplier, Daewoong in |
| @ThomasAn |
03/23/2021 1:55:29 PM |
| Medytox now owns 17% of $EOLS as a |
| @Sociolabs |
03/02/2021 12:42:00 AM |
| EOLS $CCO resigns: |
| @rhymerator |
02/26/2021 2:10:53 PM |
| znewcar1: EOLS 71% v33,6M c12.29 f33,7M morning gapNgo from 7.1 yesterdays close to a HOD14.81 got S@10.4 then |
| @stancutler |
02/19/2021 9:23:32 PM |
| whytestocks: $EOLS News Article - AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property Litiga |
| @ |
02/19/2021 3:10:48 PM |
| znewcar1: EOLS 21% v6,3M c4.46 f33,7M preMH5.6 H5.09 S4.18 |
| @samrita02 |
12/17/2020 10:50:57 PM |
| whytestocks: $EOLS must see |
| @ |
05/26/2020 4:25:45 PM |
| whytestocks: $EOLS News Article - Evolus Expands Board of Directors with Appointment of Independent Directors Pet |
| @ |
07/15/2019 3:55:40 PM |
| whytestocks: $EOLS News Article - Evolus Accelerates Next Phase of U.S. Launch of Jeuveau(TM) with '#NEWTOX NOW' |
| @ |
06/05/2019 2:45:41 PM |
| whytestocks: $EOLS News Article - Evolus Announces Publication of U.S. Phase III Pivotal Trial Results for Jeuvea |
| @ |
03/21/2019 6:45:40 PM |
| znewcar1: 20.16% 4,837,213 28.91 27,274,991 Still going! |
| @yastockboy |
02/07/2019 9:50:32 PM |
| znewcar1: 26.00% v6,892,778 c25.83 f27,274,991 News big recent vol. is impressive FDA approval. |
| @keith1950 |
02/05/2019 9:31:10 PM |